Leg Ulcers
18
2
2
11
Key Insights
Highlights
Success Rate
85% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
11.1%
2 terminated out of 18 trials
84.6%
-1.9% vs benchmark
22%
4 trials in Phase 3/4
36%
4 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 11 completed trials
Clinical Trials (18)
Modified Platform Trial Assessing Multiple Umbilical Cord-based CAMPs and SOC v SOC Alone in the Treatment of Hard-to-Heal VLUs
A Multicenter, Prospective, Controlled Modified Multi-Platform Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers.
Resolution of Sickle Cell Leg Ulcers With Voxelotor
Efficacy and Safety of Light Compression System in the Local Treatment of Mixed Leg Ulcers (PROMETHEE Clinical Investigation)
Potential Research Study Participant Registry
Physical Activity Interventions for Leg Ulcer Patients
Biatain Ag vs Biatain in the Treament of Leg Ulcers
Biatain Ibu vs. Biatain in Painful Chronic Venous Leg Ulcers
CLUE Study: Connective Tissue Disease Leg Ulcer Etiology Study
Safety Evaluation of Biatain Ibu in Painful Chronic Venous Leg Ulcers
Assessment of Efficacy & Safety for a New Wound Dressing Urgo 310 3166 in the Local Treatment of VLU or Mixed Leg Ulcers
Compression Device Versus 4-layer Compression System
The AutoloGel™ Post-Market Surveillance (TAPS) Program
Bioengineered Skin and Wound Healing
Compare Aquacel® Ag Versus Mepilex® Border Ag to Manage Bioburden in Leg Ulcers
Physiotulle vs Urgotul in the Treatment of Leg Ulcer
Legtest Multi Centre Testing of the Lively Legs Program for Promoting Compliance in Leg Ulcer Patients
A Clinical Trial on Diabetic Foot Using Peripheral Blood Derived Stem Cells for Treating Critical Limb Ischemia